The latest finding shows that the use of hormone replacement therapy (hormone replacement therapy / HRT) does not increase breast cancer risk. This generates confusion, the reason previous studies stating the opposite.

Hormone Therapy

Results of analysis of medical data records of millions of British women aged 50′s and 60′s, bright researchers, showed no relationship between the uses of this controversial therapy with an increased incidence of breast cancer.

Fears about the security of these medicines first appeared in 2002. At that time, a large study from the United States linking the hormone therapy with a host of diseases, including breast cancer and heart disease.

Because of these fears ignoring the hundreds of thousands of British women with hormone treatment, in 2005 the number of users of HRT which is beneficial to overcome symptoms of menopause, was reduced by half.

Last year, a study concluded that the use of this hormone medicines can double risk of breast cancer. This makes women’s anxiety intensified.

Osteoporosis risk

In an effort to resolve this argument, researchers from Bristol University examine whether the disease is changing as the number of women not using hormone medicines due to fear. If HRT increases the risk of breast cancer, the incidence of diseases should have declined since 2002, as the decline in use of HRT.

But the researchers found, the decline in hormone use did not affect the incidence of breast cancer. These bright researchers showed that HRT is not a trigger factor of breast cancer.

In addition, according to a study published in the Journal of Public Health, HRT is also not associated with colon cancer or hip fractures.

HRT use for menopausal symptoms such as hot flashes mood changes and sweating at night. Treatment with the hormone could be done through various methods, including tablets, implants, gels and skin patches. In the long term, these medicines could otherwise reduce the risk of osteoporosis.